tiprankstipranks
Trending News
More News >
Actuate Therapeutics, Inc. (ACTU)
NASDAQ:ACTU
US Market

Compare Actuate Therapeutics, Inc. (ACTU) vs. Competitors

Compare
33 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Actuate Therapeutics, Inc.
$2.44
$56.71M
-6.62
-63.85%
2 Buy
0 Hold
0 Sell
Moderate Buy
Agenus
$3.71
$141.69M
811.87
129.19%
1 Buy
0 Hold
0 Sell
Moderate Buy
Black Diamond Therapeutics
$2.11
$123.17M
6.18
20.79%
4 Buy
0 Hold
0 Sell
Strong Buy
Nkarta
$2.01
$154.84M
-1.76
45.33%
C4 Therapeutics
$2.70
$249.80M
-1.51
20.75%
4 Buy
0 Hold
0 Sell
Strong Buy
Kyverna Therapeutics, Inc.
$7.94
$450.75M
-1.77
231.51%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ACTU
Actuate Therapeutics, Inc.
2.44
-4.76
-66.11%
AGEN
Agenus
3.69
2.05
125.00%
BDTX
Black Diamond Therapeutics
2.15
0.47
27.98%
NKTX
Nkarta
2.18
0.63
40.65%
CCCC
C4 Therapeutics
2.56
0.34
15.32%
KYTX
Kyverna Therapeutics, Inc.
7.89
5.54
235.74%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts